Closure of Patent Foramen Ovale: Technique, Pitfalls, Complications, and Follow Up

Overview

Journal Heart

Date 2005 Mar 18

PMID 15772193

Citations 27

Authors

B Meier

Affiliations

Soon will be listed here.

Citing Articles

Dual Antiplatelet Therapy and Cancer; Balancing between Ischemic and Bleeding Risk: A Narrative Review.

Tsigkas G, Vakka A, Apostolos A, Bousoula E, Vythoulkas-Biotis N, Koufou E J Cardiovasc Dev Dis. 2023; 10(4).

PMID: 37103014 PMC: 10144375. DOI: 10.3390/jcdd10040135.

Differences in clinical and biological factors between patients with PFO-related stroke and patients with PFO and no cerebral vascular events.

Badea R, Ribigan A, Grecu N, Terecoasa E, Antochi F, Mihaila S Front Neurol. 2023; 14:1104674.

PMID: 36998773 PMC: 10043389. DOI: 10.3389/fneur.2023.1104674.

Patent foramen ovale occlusion with the Cocoon PFO Occluder. The PROS-IT collaborative project.

Testa L, Popolo Rubbio A, Squillace M, Albano F, Cesario V, Casenghi M Front Cardiovasc Med. 2023; 9:1064026.

PMID: 36712245 PMC: 9875285. DOI: 10.3389/fcvm.2022.1064026.

Advances in Percutaneous Patent Foramen Ovale Closure: From the Procedure to the Echocardiographic Guidance.

Sperlongano S, Giordano M, Ciccarelli G, Bassi G, Malvezzi Caracciolo DAquino M, Del Giudice C J Clin Med. 2022; 11(14).

PMID: 35887765 PMC: 9319304. DOI: 10.3390/jcm11144001.

Endothelialization and Inflammatory Reactions After Intracardiac Device Implantation.

Edlinger C, Paar V, Kheder S, Krizanic F, Lalou E, Boxhammer E Adv Exp Med Biol. 2022; 1401:1-22.

PMID: 35507133 DOI: 10.1007/5584_2022_712.

References

Meier B . Pacman sign during device closure of the patent foramen ovale. Catheter Cardiovasc Interv. 2003; 60(2):221-3. DOI: 10.1002/ccd.10637. View

Mas J, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G . Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001; 345(24):1740-6. DOI: 10.1056/NEJMoa011503. View

Schwerzmann M, Windecker S, Wahl A, Mehta H, Nedeltchev K, Mattle H . Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy. Heart. 2004; 90(2):186-90. PMC: 1768045. DOI: 10.1136/hrt.2002.003111. View

Krumsdorf U, Ostermayer S, Billinger K, Trepels T, Zadan E, Horvath K . Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol. 2004; 43(2):302-9. DOI: 10.1016/j.jacc.2003.10.030. View

Anzai H, Child J, Natterson B, Krivokapich J, Fishbein M, Chan V . Incidence of thrombus formation on the CardioSEAL and the Amplatzer interatrial closure devices. Am J Cardiol. 2004; 93(4):426-31. DOI: 10.1016/j.amjcard.2003.10.036. View

Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C . Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol. 2004; 44(4):750-8. DOI: 10.1016/j.jacc.2004.05.044. View

King T, Thompson S, Steiner C, Mills N . Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA. 1976; 235(23):2506-9. View

RASHKIND W . Transcatheter treatment of congenital heart disease. Circulation. 1983; 67(4):711-6. DOI: 10.1161/01.cir.67.4.711. View

Hagen P, Scholz D, Edwards W . Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984; 59(1):17-20. DOI: 10.1016/s0025-6196(12)60336-x. View

10.

Bridges N, Hellenbrand W, Latson L, Filiano J, Newburger J, Lock J . Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation. 1992; 86(6):1902-8. DOI: 10.1161/01.cir.86.6.1902. View

11.

Sharafuddin M, Gu X, TITUS J, Urness M, AMPLATZ K . Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model. Circulation. 1997; 95(8):2162-8. DOI: 10.1161/01.cir.95.8.2162. View

12.

Dearani J, Ugurlu B, Danielson G, Daly R, McGregor C, Mullany C . Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation. 1999; 100(19 Suppl):II171-5. DOI: 10.1161/01.cir.100.suppl_2.ii-171. View

13.

De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette E . Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000; 31(10):2407-13. DOI: 10.1161/01.str.31.10.2407. View

14.

Wilmshurst P, Nightingale S, Walsh K, Morrison W . Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons. Lancet. 2000; 356(9242):1648-51. DOI: 10.1016/s0140-6736(00)03160-3. View

15.

Schwerzmann M, Seiler C, Lipp E, Guzman R, Lovblad K, Kraus M . Relation between directly detected patent foramen ovale and ischemic brain lesions in sport divers. Ann Intern Med. 2001; 134(1):21-4. DOI: 10.7326/0003-4819-134-1-200101020-00009. View

16.

Mohr J, Thompson J, Lazar R, Levin B, Sacco R, Furie K . A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2002; 345(20):1444-51. DOI: 10.1056/NEJMoa011258. View

17.

Khairy P, ODonnell C, Landzberg M . Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med. 2003; 139(9):753-60. DOI: 10.7326/0003-4819-139-9-200311040-00010. View